As of Aug 31
| -1.25 / -4.87%|
The 6 analysts offering 12-month price forecasts for Insmed Inc have a median target of 31.00, with a high estimate of 38.00 and a low estimate of 25.00. The median estimate represents a +26.84% increase from the last price of 24.44.
The current consensus among 6 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.